Filing Details
- Accession Number:
- 0001209191-11-031779
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-05-31 13:17:53
- Reporting Period:
- 2011-05-26
- Filing Date:
- 2011-05-31
- Accepted Time:
- 2011-05-31 13:17:53
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1145404 | Cornerstone Therapeutics Inc | CRTX | Pharmaceutical Preparations (2834) | 043523569 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1317664 | Alan Roberts | C/O Cornerstone Therapeutics 1255 Crescent Green Drive, Suite 250 Cary NC 27518 | Vp, Scientific Affairs | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2011-05-26 | 5,850 | $7.60 | 68,250 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.60 to $7.61, inclusive. The reporting person undertakes to provide to Cornerstone Therapeutics Inc., any security holder of Cornerstone Therapeutics Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.